Developing a Cancer database for Shirdi Sai Baba Cancer and Research Centre.
Not Applicable
Completed
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2018/10/016139
- Lead Sponsor
- Dr Kanav Khera Proff
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 130
Inclusion Criteria
Any patient irrespective of age and sex diagnosed with cancer.
Exclusion Criteria
patients not willing to participate
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A complete, precise and accurate data of all cancer patients would be <br/ ><br>registered.Timepoint: 2 years
- Secondary Outcome Measures
Name Time Method A complete, precise and accurate data of all cancer patients would be <br/ ><br>registered.Timepoint: 2 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cancer registry data collection for C00-D49 neoplasms in CTRI/2018/10/016139?
How does the Shirdi Sai Baba Cancer Registry compare to existing cancer databases in capturing RAS mutant pancreatic cancer data?
What biomarkers are used in CTRI/2018/10/016139 to predict treatment response in C00-D49 neoplasms?
What adverse events are associated with standard-of-care treatments for C00-D49 neoplasms in India?
How do PRMT5 inhibitors and MTAP deletion targeting therapies synergize with existing cancer treatments?